Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,051
Closed -$7.71K 4084
2025
Q2
$7.71K Sell
17,051
-12,000
-41% -$5.22K ﹤0.01% 3657
2025
Q1
$11.8K Hold
29,051
﹤0.01% 3551
2024
Q4
$19.2K Buy
29,051
+7,246
+33% +$5.03K ﹤0.01% 3545
2024
Q3
$17K Buy
21,805
+9,900
+83% +$7.57K ﹤0.01% 3531
2024
Q2
$7K Buy
+11,905
New +$9.88K ﹤0.01% 3463
2021
Q4
Sell
-18,581
Closed -$148K 3496
2021
Q3
$148K Buy
18,581
+698
+4% +$5.75K ﹤0.01% 2784
2021
Q2
$131K Sell
17,883
-10,864
-38% -$75.8K ﹤0.01% 2756
2021
Q1
$174K Buy
+28,747
New +$221K ﹤0.01% 2648
2020
Q4
Sell
-12,297
Closed -$83K 2899
2020
Q3
$83K Buy
+12,297
New +$110K ﹤0.01% 2259

Other funds holding VXRT

HighTower Advisors's VXRT Position: Q3 2025 in Review

HighTower Advisors sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 17,051 shares — an estimated $7.71K sold.

HighTower Advisors first reported a position in VXRT in Q3 2020 and held it in 9 quarters. The position peaked at $174K in Q1 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • HighTower Advisors reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • HighTower Advisors sold 17,051 Vaxart shares in Q3 2025, an estimated $7.71K.
  • HighTower Advisors first reported a position in Vaxart in Q3 2020 and held it in 9 quarters.
  • HighTower Advisors's Vaxart position peaked at $174K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.